Drugs / WCK 771
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01875939 | Jun 2013 | — | Wockhardt | Completed | No outcome recorded |
| Phase 1 | NCT05640531 | Dec 2011 → Feb 2012 | — | Wockhardt | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 2
| Date | Issuer | Release |
|---|---|---|
| 2020-01-16 | Wockhardt | Regulatory INDIA’S FIRST NEW DISCOVERY ANTIBIOTICS FROM WOCKHARDT GRANTED INDIAN REGULATORY APPROVAL wockhardt.com ↗
India’s First New Discovery Antibiotics from Wockhardt Granted Indian Regulatory Approval |
| 2014-08-31 | Wockhardt | Regulatory Wockhardt’s drug discovery gets a boost with fast track approval by USFDA wockhardt.com ↗
WCK 771 and WCK 2349, the two anti infective drugs from Wockhardt, get QIDP status |
All press releases naming this drug 2 releases
| Date | Issuer | Release |
|---|---|---|
| 2020-01-16 | Wockhardt | INDIA’S FIRST NEW DISCOVERY ANTIBIOTICS FROM WOCKHARDT GRANTED INDIAN REGULATORY APPROVAL wockhardt.com ↗ |
| 2014-08-31 | Wockhardt | Wockhardt’s drug discovery gets a boost with fast track approval by USFDA wockhardt.com ↗ |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WCK 771 | “The subjects completing the food effect study (i.e., Period 1 and Period 2) will be administered WCK 771 800 mg as an intravenous infusion in fasting state in Period 3 of the study.” NCT01875939 ↗ |
| Route | Intravenous | “WCK 771 800 mg as an intravenous infusion” NCT01875939 ↗ |